Trial intelligence / Profile preview

Effects of SGLT2 inhibitors on appetite in patients with type 2 diabetes

jRCT1050220190Not yet recruiting

Sponsor
Kyoto University Graduate School of Medicine
Start
Mar 2023
Countries
1
01

Overview

Open-label, single-arm trial in type 2 diabetes mellitus (T2DM), sponsored by Kyoto University Graduate School of Medicine. Primary endpoints: Change in fasting plasma glucose at 24 weeks and Change in appetite-related Power of Food Scale (Japanese version) at 24 weeks. Planned start Mar 2023; status: not yet recruiting.

02

Conditions

type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on jRCT1050220190.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT1050220190.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call